Company Filing History:
Years Active: 2017-2025
Title: Shinnosuke Machida: Innovator in Pharmaceutical Chemistry
Introduction
Shinnosuke Machida is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work focuses on enhancing the stability and efficacy of pharmaceutical agents.
Latest Patents
One of Machida's latest patents is for a PACAP stabilized peptide. The purpose of this invention is to provide a PACAP peptide that exhibits increased stability. The problem is addressed by the discovery that substituting a carboxy group of the position 3 and/or position 8 aspartic acid in the PACAP sequence with tetrazole significantly enhances stability. Another notable patent is for an alkynyl indazole derivative and its use. The main objective of this invention is to provide a novel compound that has VEGF receptor tyrosine kinase inhibitory activity. This compound is useful as an active ingredient for treating diseases associated with angiogenesis or edema, such as age-related macular degeneration.
Career Highlights
Shinnosuke Machida is currently employed at Senju Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving drug stability and efficacy, which is crucial for developing effective treatments.
Collaborations
Machida collaborates with esteemed colleagues, including Takeshi Nakajima and Norihiko Takeda. Their combined expertise enhances the research and development efforts at Senju Pharmaceutical Co., Ltd.
Conclusion
Shinnosuke Machida is a dedicated inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative patents reflect his commitment to improving therapeutic options for patients.